Skip to main content
Premium Trial:

Request an Annual Quote

Health Discovery Inks Second Biomarker, Pathway Deal with MD Anderson Cancer Center

NEW YORK, Jan. 26 (GenomeWeb News) - Health Discovery said today that it has signed an agreement acquiring the first option to obtain the exclusive worldwide rights to commercialize prostate cancer biomarkers or pathways identified by the company as part of a collaboration with the University of Texas, MD Anderson Cancer Center.


The option for the royalty-bearing commercialization license was granted by the MD Anderson, said Health Discovery. Additional terms of the deal, which the comapny said is its second with the cancer center, were not disclosed.



The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.